Insiders SpectraCure AB

Equities

Delayed Nasdaq Stockholm Other stock markets 14:51:04 16/05/2024 BST			5-day change	1st Jan Change
2.77 ^SEK	-4.48%		-7.36%	-28.24%

02-23	Spectracure AB Continues in the Process of Initiating A Clinical Study, for Primary Localised Prostate Cancer	CI
02-22	SpectraCure AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

SpectraCure AB Announces Board Appointments	16/05/22	CI
SpectraCure : The Nomination Committee's proposal for election of board members in SpectraCure AB	15/04/21	AQ
SpectraCure AB Announces Decline Re-Election of Masoud Khayyami as Board Member	15/04/21	CI

No results for this search